Specifically, genetic variants of the MS4A gene cluster and, more recently, of TGFBR2 and NECTIN2 are associated with increased CSF sTREM2 and reduced AD risk (Deming et al, 2019; Wang et al, 2024). Here, CSF2 is linked to Alzheimer disease.